steer trial semaglutide The numbers are in. SELECT trial: 20% reduction in major cardiovascular events — in people who weren't even diabetic. This isn't just a weight loss drug anymore. It's a cardiovascular breakthrough. Full Tirzepatide versus Semaglutide Once Weekly

Despite strong efficacy, systemic barriers like coverage gaps and high out-of-pocket costs, especially for obesity indications, continue to drive abandonment

Another clinical trial with 636 participants was conducted over 52 weeks to compare the effects of tirzepatide and dulaglutide

Longer trials are needed to fully assess the efficacy of this combination treatment for weight loss to see whether the weight-loss results are sustained

10.1074/jbc.M702294200 8 CorselloT.KomaravelliN.CasolaA

The MHRA has issued public warnings about the sale of unlicensed peptides and research chemicals marketed for human use, noting that such products may be mislabelled, contaminated, or of unknown potency